Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:https://ncihub.cancer.gov/groups/ncihubshutdown/overview
close

Tags: nanoparticles nanomedicine

All Categories (1-1 of 1)

  1. Guide to NCL In Vivo Studies: Efficacy, Pharmacokinetics & Toxicology

    08 Sep 2022 | Datasets | Contributor(s):

    By Stephan Stern

    Novel nanoformulated chemotherapeutics and diagnostics require demonstration of efficacy and safety in appropriate animal models prior to clinical translation of the concept. Pharmacokinetic...

    https://ncihub.cancer.gov/publications/309/?v=1